Predictive genetic testing for cardiovascular diseases: Impact on carrier children

American Journal of Medical Genetics, Part A

Volumn 146, Issue 24, 2008, Pages 3136-3146

  Meulenkamp, Tineke M ^a   Tibben, Aad ^b   Mollema, Eline D ^a   Van Langen, Irene M ^a   Wiegman, Albert ^a   De Wert, Guido M ^c   De Beaufort, Inez D ^d   Wilde, Arthur A M ^a   Smets, Ellen M A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Children; DNA testing; Familial hypercholesterolemia; Genetic counseling; Hypertrophic cardiomyopathy; Long QT syndrome; Predictive genetic testing

Indexed keywords

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; COPING BEHAVIOR; DNA DETERMINATION; DRUG EFFICACY; DRUG USE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INHERITANCE; LIFESTYLE MODIFICATION; LONG QT SYNDROME; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITATIVE ANALYSIS;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; COGNITION; DEMOGRAPHY; EMOTIONS; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MUTATION; PARENTS;

EID: 57149094879     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32592     Document Type: Article

References (41)

1. Alcalai R, Seidman JG, Seidman CE. 2008. Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics. J Cardiovasc Electrophysiol 19:104-110.
2. Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJ, Hutten BA. 2007. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 27:1803-1810 .
3. Bernhardt BA, Tambor ES, Fraser G, Wissow LS, Geller G. 2003. Parents' and children's attitudes toward the enrollment of minors in genetic susceptibility research: Implications for informed consent. Am J Med Genet Part A 116A:315-323.
4. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K. 2006. Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clin Genet 70:374-381.
5. Chen S, Zhang L, Bryant RM, Vincent GM, Flippin M, Lee JC, Brown E, Zimmerman F, Rozich R, Szafranski P, Oberti C, Sterba R, Maranqi D, Tchou PJ, Chung MK, Wang Q. 2003. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet 63:273-282.
6. Clarke A. 1994. The genetic testing of children. Working party of the clinical genetics society (UK). J Med Genet 31:785-797.
7. Codori AM, Petersen GM, Boyd PA, Brandt J, Giardiello FM. 1996. Genetic testing for cancer in children. Short-term psychological effect. Arch Pediatr Adolesc Med 150:1131-1138.
8. Codori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD, Booker SV, Picarello K, Giardiello FM. 2003. Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. Am J Med Genet Part A 116A:117-128.
9. Jongh de S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HSA, Last BF. 2003. Quality of life, anxiety, and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr 92:1096-1101.
10. Duncan RE, Delatycki MB. 2006. Predictive genetic testing in young people for adult-onset conditions: Where is the empirical evidence? Clin Genet 69:8-16.
11. Edgar KA, Skinner TC. 2003. Illness representations and coping as predictors of emotional well-being in adolescents with type 1 diabetes. J Pediatr Psychol 28:485-493.
12. Eiser C, Kopel SJ. 1997. Children's perceptions of health and illness. In: Petrie KJ, Weinman JA, editors. Perceptions of health and illness. Current research and applications. Amsterdam: Harwood Academic Publishers. pp 47-76.
13. Fanos JH. 1997. Developmental tasks of childhood and adolescence: Implications for genetic testing. Am J Med Genet 71:22-28.
14. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. 2008. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 117:2184-2191.
15. Hendriks KSWH, Grosfeld FJM, van Tintelen JP, van Langen IM, Wilde AAM, van den Bout J, ten Kroode HFJ. 2005. Can parents adjust to the idea that their child is at risk for a sudden death? Psychological impact of risk for Long QT syndrome. Am J Med Genet Part A 138A:107-112.
16. Huijgen R, Vissers MN, Defesche JC, Lansberg PJ, Kastelein JJ, Hutten BA. 2008. Familial hypercholesterolemia: Current treatment, advances in management. Expert Rev Cardiovasc Ther 6:567-581.
17. Keren A, Syrris P, McKenna WJ. 2008. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 5:158-168.
18. Law GU, Kelly TP, Huey D, Summerbell C. 2002. Self-management and well-being in adolescents with diabetes mellitus: Do illness representations play a regulatory role? J Adolesc Health 31:381-385.
19. Leventhal H, Brissette I, Leventhal E. 2003. The Common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H, editors. The self-regulation of health and illness behavior. London and New York: Routledge. pp 42-65.
20. Malpas PJ. 2005. Why tell asymptomatic children of the risk of an adult-onset disease in the family but not test them for it? J Medical Ethics 32:639-642.
21. Marteau T, Weinman J. 2006. Self-regulation and the behavioral response to DNA risk information: A theoretical analysis and framework for future research. Soc Sci Med 62:1360-1368.
22. Marteau T, Senior V, Humphries SE, Bobrow M, Cranston T, Crook MA, Day L, Fernandez M, Horne R, Iversen A, Jackson Z, Lynas J, Middleton-Price H, Savine R, Sikorski J, Watson M, Weinman J, Wierzbicki AS, Wray R. 2004. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial. Am J Med Genet A 128A:285-293.
23. Mason J. 2002. Qualitative researching, 2nd edition. London: Sage. 224 pp.
24. Mays N, Pope C. 1995. Qualitative research: Rigour and qualitative research. BMJ 311:109-112.
25. Michie S, Bobrow M, Marteau TM. 2001. on behalf of the FAP Collaborative Research Group. Predictive genetic testing in children and adults: A study of emotional impact. J Med Genet 38:519-526.
26. Patenaude AF, Kupst MJ. 2005. Psychosocial functioning in pediatric cancer. J Pediatr Psychol 30:9-27.
27. Priori SG, Napolitano C, Schwartz PJ. 1999. Low penetrance in the long-QT syndrome: Clinical impact. Circulation 99:529-533.
28. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. 2003. Risk stratification in the long-QT syndrome. N Eng J Med 348:1866-1874.
29. Rees G, Fry A, Cull A, Sutton S. 2004. Illness perceptions and distress in women at increased risk of breast cancer. Psychol Health 19:749-765.
30. Roden DM. 2008. Clinical practice. Long-QT syndrome. N Engl J Med 358:169-176.
31. Seggewiss H, Rigopoulos A. 2003. Management of hypertrophic cardiomyopathy in children. Paediatr Drugs 5:663-672.
32. Senior V, Marteau TM, Weinman J. 2004. Self-reported adherence to cholesterol lowering medication in patients with familial hypercholesterolemia: The role of illness perceptions. Card Drugs Ther 18:475-481.
33. Shiloh S. 2006. Illness respresentations, self-regulation, genetic counseling: A theoretical review. J Gen Couns 15:325-336.
34. Smets EMA, Stam MMH, Meulenkamp TM, van Langen IM, Wilde AAM, Wiegman A, de Wert GM, Tibben A. 2008. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet Part A 146A:700-707.
35. Soutar AK, Naoumova RP. 2007. Mechanisms of disease: Genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4:214-225.
36. Stam H, Hartman EE, Deurloo JA, Groothoff J, Grootenhuis MA. 2006. Young adult patients with a history of pediatric disease: Impact on course of life and transition into adulthood. J Adolesc Health 39:4-13.
37. Tonstad S. 2001. Stratification of risk in children with familial hypercholesterolemia with focus on psychosocial issues. Nutr Metab Cardiovasc Dis 11:64-67.
38. van der Zaag-Loonen HJ, Grootenhuis MA, Last BF, Derkx HHF. 2004. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res 13:1011-1019.
39. Langen van IM. 2005. Clinical genetic care in diseases predisposing to sudden cardiac death. Thesis. University of Amsterdam. http://dare.uva.nl.
40. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJG, Kastelein JJP. 2004. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial. JAMA 292:331-337.
41. Zhang L, Vincent GM, Baralle M, Baralle FE, Anson BD, Benson DW, Whiting B, Timothy KW, Carlquist J, January CT, Keating MT, Splawski I. 2004. An intronic mutation causes long QT syndrome. J Am Coll Cardiol 44:1283-1291.